| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |